Mohamed Algamal is a visionary leader with over 17 years of transformative experience in the pharmaceutical industry. As the founder and CEO of Hemara Bio, a biotechnology company focused on rare diseases, hematology, and oncology, Mohamed drives innovation that empowers patients across the Middle East.

His leadership includes global roles at international pharmaceutical companies such as Emmaus Life Sciences, Amgen, Taiba Rare, Servier, and Baxter. Mohamed is known for spearheading collaborations with renowned medical institutions. His expertise in hematology, rare diseases, and oncology continues to shape groundbreaking healthcare solutions that enhance patient outcomes and set new industry standards.